A detailed history of Td Asset Management Inc transactions in Pfizer Inc stock. As of the latest transaction made, Td Asset Management Inc holds 2,481,065 shares of PFE stock, worth $69.4 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
2,481,065
Previous 2,413,148 2.81%
Holding current value
$69.4 Million
Previous $69.5 Million 0.9%
% of portfolio
0.07%
Previous 0.07%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

BUY
$25.89 - $29.73 $1.76 Million - $2.02 Million
67,917 Added 2.81%
2,481,065 $68.8 Million
Q4 2023

Feb 12, 2024

SELL
$26.13 - $33.94 $13.9 Million - $18 Million
-531,149 Reduced 18.04%
2,413,148 $69.5 Million
Q3 2023

Oct 27, 2023

SELL
$32.09 - $37.51 $14.7 Million - $17.2 Million
-458,930 Reduced 13.49%
2,944,297 $97.7 Million
Q2 2023

Aug 09, 2023

SELL
$36.12 - $41.79 $12 Million - $13.9 Million
-333,433 Reduced 8.92%
3,403,227 $125 Million
Q1 2023

May 10, 2023

SELL
$39.39 - $51.28 $207 Million - $269 Million
-5,242,825 Reduced 58.39%
3,736,660 $152 Million
Q4 2022

Feb 06, 2023

SELL
$41.75 - $54.5 $14 Million - $18.2 Million
-334,841 Reduced 3.59%
8,979,485 $460 Million
Q3 2022

Nov 07, 2022

SELL
$43.76 - $53.42 $3.15 Million - $3.85 Million
-72,055 Reduced 0.77%
9,314,326 $411 Million
Q2 2022

Aug 04, 2022

BUY
$46.53 - $55.17 $19.1 Million - $22.6 Million
409,753 Added 4.56%
9,386,381 $492 Million
Q1 2022

May 10, 2022

BUY
$45.75 - $56.69 $53.5 Million - $66.3 Million
1,169,738 Added 14.98%
8,976,628 $465 Million
Q4 2021

Feb 10, 2022

BUY
$41.32 - $61.25 $173 Million - $257 Million
4,192,157 Added 115.97%
7,806,890 $461 Million
Q3 2021

Nov 09, 2021

BUY
$39.25 - $50.42 $9.84 Million - $12.6 Million
250,758 Added 7.45%
3,614,733 $155 Million
Q2 2021

Aug 11, 2021

BUY
$35.91 - $40.68 $6.56 Million - $7.43 Million
182,651 Added 5.74%
3,363,975 $144 Million
Q1 2021

May 14, 2021

BUY
$33.49 - $37.77 $539,389 - $608,323
16,106 Added 0.51%
3,181,324 $115 Million
Q4 2020

Feb 16, 2021

BUY
$33.47 - $42.56 $3.12 Million - $3.97 Million
93,235 Added 3.04%
3,165,218 $117 Million
Q3 2020

Nov 10, 2020

SELL
$31.75 - $37.25 $63.8 Million - $74.8 Million
-2,008,244 Reduced 39.53%
3,071,983 $113 Million
Q2 2020

Aug 13, 2020

SELL
$30.12 - $36.54 $165 Million - $200 Million
-5,466,213 Reduced 51.83%
5,080,227 $166 Million
Q1 2020

May 15, 2020

BUY
$27.03 - $38.62 $30.2 Million - $43.2 Million
1,119,046 Added 11.87%
10,546,440 $344 Million
Q4 2019

Feb 11, 2020

SELL
$32.92 - $37.36 $2.76 Million - $3.13 Million
-83,715 Reduced 0.88%
9,427,394 $369 Million
Q3 2019

Nov 07, 2019

BUY
$32.49 - $42.13 $6.33 Million - $8.21 Million
194,799 Added 2.09%
9,511,109 $342 Million
Q2 2019

Aug 01, 2019

BUY
$36.98 - $41.52 $2.36 Million - $2.65 Million
63,868 Added 0.69%
9,316,310 $404 Million
Q1 2019

May 08, 2019

BUY
$37.5 - $41.2 $19.8 Million - $21.8 Million
528,890 Added 6.06%
9,252,442 $393 Million
Q4 2018

Feb 01, 2019

BUY
$38.47 - $43.86 $4.98 Million - $5.68 Million
129,557 Added 1.51%
8,723,552 $381 Million
Q3 2018

Nov 01, 2018

SELL
$34.47 - $41.81 $9.48 Million - $11.5 Million
-274,878 Reduced 3.1%
8,593,995 $379 Million
Q2 2018

Jul 31, 2018

BUY
$32.98 - $35.16 $4.89 Million - $5.22 Million
148,400 Added 1.7%
8,868,873 $322 Million
Q1 2018

May 11, 2018

BUY
$31.91 - $37.02 $22.6 Million - $26.2 Million
707,224 Added 8.83%
8,720,473 $309 Million
Q4 2017

Feb 02, 2018

BUY
$33.26 - $35.29 $14.2 Million - $15.1 Million
427,732 Added 5.64%
8,013,249 $290 Million
Q3 2017

Nov 09, 2017

BUY
$31.0 - $34.15 $235 Million - $259 Million
7,585,517
7,585,517 $271 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.